Plainsboro, NJ, United States of America

Young Mi Khulman

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young Mi Khulman: Innovator in Pharmaceutical Development

Introduction

Young Mi Khulman is a notable inventor based in Plainsboro, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptor pathways. Her work is essential in addressing various medical conditions that affect millions of people worldwide.

Latest Patents

Young Mi Khulman holds 1 patent related to her innovative work. The patent focuses on processes and intermediates useful in the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid, which is an S1P1 receptor modulator. This compound is particularly useful in treating S1P1 receptor-associated disorders, including autoimmune diseases, transplant rejection, and various inflammatory conditions.

Career Highlights

Young Mi Khulman is currently employed at Arena Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work at Arena Pharmaceuticals has positioned her as a key player in the pharmaceutical industry, contributing to the development of innovative therapies.

Collaborations

Throughout her career, Young Mi Khulman has collaborated with esteemed colleagues, including Antonio Garrido Montalban and Daniel J Buzard. These collaborations have enhanced her research and expanded the impact of her inventions.

Conclusion

Young Mi Khulman is a pioneering inventor whose work in pharmaceutical development is making a difference in the treatment of complex medical conditions. Her contributions to the field are invaluable, and her innovative spirit continues to drive advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…